Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

January 17, 2024

Study Completion Date

January 18, 2024

Conditions

Circulating Tumor DNAMetastatic Prostate Cancer

Interventions

OTHER

Blood sample

2 tubes Cell free DNA are taken during a blood sample already planned in the patient's care.

OTHER

Urine sample

Urine sample is taken during the consultation carried out for the patient's care

Trial Locations (1)

University hospital, Tours

All Listed Sponsors

lead

University Hospital, Tours

OTHER